🇺🇸 FDA
Patent

US 8642751

MicroRNA inhibitors comprising locked nucleotides

granted A61KA61K31/7105A61P

Quick answer

US patent 8642751 (MicroRNA inhibitors comprising locked nucleotides) held by MIRAGEN THERAPEUTICS, INC. expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MIRAGEN THERAPEUTICS, INC.
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/7105, A61P, A61P9/00, A61P9/04